a:5:{s:8:"template";s:7658:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1" name="viewport"/>
<title>{{ keyword }}</title>
</head>
<style rel="stylesheet" type="text/css">@charset "UTF-8";.has-drop-cap:not(:focus):first-letter{float:left;font-size:8.4em;line-height:.68;font-weight:100;margin:.05em .1em 0 0;text-transform:uppercase;font-style:normal} html{font-family:sans-serif;-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%}body{margin:0}footer,header,nav{display:block}a{background-color:transparent}a:active,a:hover{outline:0} html{font-size:10px;-webkit-tap-highlight-color:transparent}body{font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:14px;line-height:1.42857;color:#333;background-color:#fff}a{color:#00aeef;text-decoration:none}a:focus,a:hover{color:#0076a3;text-decoration:underline}a:focus{outline:-webkit-focus-ring-color auto 5px;outline-offset:-2px}h2,h3{font-family:inherit;font-weight:500;line-height:1.1;color:inherit}h2,h3{margin-top:20px;margin-bottom:10px}h2{font-size:30px}h3{font-size:24px}p{margin:0 0 10px}ul{margin-top:0;margin-bottom:10px}.container{margin-right:auto;margin-left:auto;padding-left:15px;padding-right:15px}.container:after,.container:before{content:" ";display:table}.container:after{clear:both}@media (min-width:768px){.container{width:750px}}@media (min-width:992px){.container{width:970px}}@media (min-width:1200px){.container{width:1170px}}.container-fluid{margin-right:auto;margin-left:auto;padding-left:15px;padding-right:15px}.container-fluid:after,.container-fluid:before{content:" ";display:table}.container-fluid:after{clear:both}.row{margin-left:-15px;margin-right:-15px}.row:after,.row:before{content:" ";display:table}.row:after{clear:both}.col-md-3,.col-sm-12,.col-sm-3,.col-sm-6,.col-xs-12{position:relative;min-height:1px;padding-left:15px;padding-right:15px}.col-xs-12{float:left}.col-xs-12{width:100%}@media (min-width:768px){.col-sm-12,.col-sm-3,.col-sm-6{float:left}.col-sm-3{width:25%}.col-sm-6{width:50%}.col-sm-12{width:100%}}@media (min-width:992px){.col-md-3{float:left}.col-md-3{width:25%}}@-ms-viewport{width:device-width} #footer-section,.footer-bottom,.header-bottom,.header-top{width:100%}.compare-panel{height:100%}#section-body,.header-section-2,.navi>ul>li{position:relative}.compare-panel{position:fixed}.navi a{display:inline-block}.header-top{display:table}.header-section-2 .logo{display:table-cell}.footer-bottom p,.footer-widget .widget-title,.navi>ul{margin:0}.container,ul{padding:0}.header-bottom .header-nav,.logo,.navi>ul>li{float:left}.header-section-2 .logo{float:none}.header-section-2 .logo{vertical-align:middle!important}.compare-panel{right:0}.compare-panel{top:0}.navi>ul:after,.navi>ul:before{content:" ";display:table}.navi>ul:after{clear:both}a{-webkit-transition:.3s;transition:.3s}.compare-panel{-webkit-transition:all .9s cubic-bezier(.19,1,.22,1) 0s;transition:all .9s cubic-bezier(.19,1,.22,1) 0s}@media (max-width:768px){.container{padding-right:15px;padding-left:15px}}@media (max-width:767px){.container{width:480px}}@media (max-width:481px){.container{width:100%}}body{text-rendering:optimizeLegibility;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale;padding-right:0!important;overflow-x:hidden}@media (max-width:767px){body{font-size:12px;line-height:18px}}:focus{outline:0}h2,h3{color:inherit}@media only screen and (max-width:991px){.header-bottom{display:none}}.header-section-2{z-index:11}.header-section-2 .logo{padding-left:20px}.header-section-2 .header-top{min-height:70px}@media (max-width:991px){.header-section-2 .header-top{padding:10px 15px;height:45px;min-height:0}}.header-section-2 .navi>ul>li>a{padding:0 15px;line-height:46px}.navi li,.navi ul{list-style:none}.navi a{padding:15px;-webkit-user-select:none}.navi>ul>li{overflow:hidden}#section-body{padding-bottom:40px}.compare-panel{z-index:1000;width:240px;background-color:#fff;box-shadow:0 2px 4px 0 rgba(0,0,0,.2);-webkit-transform:translate3d(100%,0,0);transform:translate3d(100%,0,0)}.widget-top{margin-bottom:17px}.widget-body{font-size:14px}.footer-widget{margin-bottom:30px}@media (min-width:768px) and (max-width:991px){.footer-widget{margin-bottom:30px}}@media (max-width:767px){.footer-widget{margin-bottom:30px}}.footer-widget .widget-title{font-size:18px;line-height:24px}.footer{margin-bottom:-30px;padding:100px 0 70px;background-color:#363636}@media (max-width:767px){.footer{padding:45px 0 35px}}.footer-bottom{padding:30px 0 25px;font-size:14px}@media (max-width:767px){.footer-bottom{padding:15px 0}}@media (max-width:767px){.footer-bottom div[class*=col-]{margin-bottom:15px;text-align:center}.footer-bottom div[class*=col-]:last-child{margin:0}}p{margin:0 0 20px 0}h2{font-size:20px;line-height:24px;font-weight:500;margin:0 0 20px}@media (max-width:767px){h2{font-size:16px;line-height:22px;margin-bottom:15px}}h3{font-size:18px;line-height:22px;font-weight:500;margin:0 0 20px}@media (max-width:767px){h3{font-size:14px;line-height:18px;margin-bottom:15px}}@media (max-width:767px){p{font-size:12px;line-height:22px;margin-bottom:15px}} @font-face{font-family:Raleway;font-style:normal;font-weight:700;src:local('Raleway Bold'),local('Raleway-Bold'),url(https://fonts.gstatic.com/s/raleway/v14/1Ptrg8zYS_SKggPNwJYtWqZPBQ.ttf) format('truetype')}@font-face{font-family:Raleway;font-style:normal;font-weight:800;src:local('Raleway ExtraBold'),local('Raleway-ExtraBold'),url(https://fonts.gstatic.com/s/raleway/v14/1Ptrg8zYS_SKggPNwIouWqZPBQ.ttf) format('truetype')}@font-face{font-family:Roboto;font-style:normal;font-weight:900;src:local('Roboto Black'),local('Roboto-Black'),url(https://fonts.gstatic.com/s/roboto/v20/KFOlCnqEu92Fr1MmYUtfBBc9.ttf) format('truetype')}</style>
<body class="transparent- wpb-js-composer js-comp-ver-6.1 vc_responsive cornerstone-v3_5_4">
<header class="header-section-2 houzez-header-main houzez-user-logout" id="header-section">
<div class="header-top">
<div class="logo logo-desktop">
<a href="#">
<h2>
{{ keyword }}
</h2>
</a>
</div>
</div>
<div class="header-bottom" data-sticky="1">
<div class="container-fluid">
<div class="row">
<div class="col-sm-12 col-xs-12">
<div class="header-nav">
<nav class="navi main-nav">
<ul class="" id="main-nav"><li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-home menu-item-613" id="menu-item-613"><a href="#">Home</a></li>
<li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-614" id="menu-item-614"><a href="#">Blog</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-645" id="menu-item-645"><a href="#">About Us</a></li>
<li class="menu-item menu-item-type-custom menu-item-object-custom menu-item-827" id="menu-item-827"><a href="#">Contact Us</a></li>
</ul> </nav>
</div>
</div>
</div>
</div>
</div>
</header>
<div class="" id="section-body">
<div class="container">
<div class="compare-panel" id="compare-controller">
<div id="compare-properties-basket">
</div>
</div>
{{ text }}
 </div> 
</div> 
<footer id="footer-section">
<div class="footer footer-v2">
<div class="container">
<div class="row">
<div class="col-md-3 col-sm-6 col-xs-12"><div class="footer-widget widget-about" id="houzez_about_widget-1"><div class="widget-top"><h3 class="widget-title" style="color:#FFF">Related</h3></div>
<div class="widget-body" style="color:#FFF">
{{ links }}
</div>
</div></div></div>
</div>
</div>
<div class="footer-bottom">
<div class="container">
<div class="row">
<div class="col-md-3 col-sm-3">
<div class="footer-col">
<p>{{ keyword }} 2021</p>
</div>
</div>
</div>
</div>
</div>
</footer>
</body>
</html>";s:4:"text";s:19099:"Monthly Subscription. Nasdaq: GTBP. About GTBP. Big Cap Pro. GT Biopharma, Inc., formerly OXIS International, Inc., is an immuno-oncology company. Read Press Release. Our TriKE™ platform is designed to harness and enhance the cancer killing abilities of a patient's immune system's natural killer cells (NK cells). GT Biopharma, Inc () Stock Market info Recommendations: Buy or sell GT Biopharma stock? The company announced that it has completed a private offering, even in the midst of the COVID-19 pandemic. OXI | Complete GT Biopharma Inc. stock news by MarketWatch. Real-time trade and investing ideas on GT Biopharma Inc GTBP from the largest community of traders and investors. Year End Results. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … Stock Information. Follow GTBP. 2 of the analysts rate the stock as a “Buy”. GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immuno-oncology therapeutic products based on our proprietary TriKE™ NK cell engager platform. GT Biopharma, Inc. (NASDAQ:GTBP) GT Biopharma, Inc., formerly OXIS International, Inc., is an immuno-oncology company. In comparing GT Biopharma, Inc. (GTBP)’s stock with other industry players reveals that stock’s current price change of +7.78% and that of +305.62% over the past 12 months is in better position with that of Amgen Inc (AMGN) which saw its stock price raised by 0.23% in the last trading and went through an increase of 10.74% in past 12-month trading. 52 Week Range. GT Biopharma Announces the Appointments of Gregory Berk, M.D. View detailed financial information, real-time news, videos, quotes and analysis on GT Biopharma Inc (NASDAQ:GTBP). By Staff. Stock analysis for GT Biopharma Inc (GTBP:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The stock’s 5-day price performance is 14.82%, and it has moved by 95.43% in 30 days. Why? Sign Up. to Consulting Chief Scientific Officer . Twitter. GT Biopharma, Inc. (GTBP) registered a 9.32% upside in the last session and has traded in the green over the past 5 sessions. $59.99. Comparatively, ContraFect has a beta of 1.08, indicating that its stock price is 8% more volatile than the S&P 500. NASDAQ 0.00%.  At the close of trading, the stock’s price was $11.54, to imply an increase of 16.57% or $1.64 in intraday trading. The Company is engaged in discovering, developing and commercializing therapeutics from its product platform in a range of disease areas. March 9, 2021. 0.50 0.00 (0.0%) Upgrade to Real-Time Market Closed . Pinterest. The purpose of this Information Statement is to notify our stockholders that (a) on December 30, 2020, the Board of Directors (the 'Board') of GT Biopharma, Inc., a Delaware corporation (the 'Company' 'we,' 'us' or 'our'), and (b) on January 14, 2021, the holders of at least a majority of our common stock, par value $0.001 per share (the 'common stock') and Preferred Stock (as defined … 0 analysts have rated the stock as a Sell or Underperform. Their average twelve-month price target is $23.00, predicting that the stock has a possible upside of 44.75%. Apr 26, 2021. The company’s stock price has collected 21.89% of gains in the last five trading sessions. MKT Cap. GT Biopharma, Inc. (NASDAQ:GTBP)’s traded shares stood at 645,513 during the last session, with the company’s beta value hitting 0.08. We HATEcancer and we LOVE any company that has a mission to fight cancer. ZIP XLS HTML. GT Biopharma, Inc. Common Stock (GTBP) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. Real-time trade and investing ideas on GT Biopharma Inc GTBP from the largest community of traders and investors. 6 posts Penny Stock News; X; GT Biopharma to Present at The Virtual 33rd Annual Roth Conference. 2 Wall Street analysts have issued ratings and price targets for GT Biopharma in the last 12 months. Change. 2 analysts offering their recommendations for the stock have an average rating of 2.00, where 0 rate it as a Hold and 0 think it is a “Overweight”. The Company develops drugs focused on the treatment of cancer. for only. Based on these gigs, the overall price performance for the year is 83.82%. 52 Week Range. GT Biopharma (OTCMKTS: GTBP) has set the foundation for strong growth ahead. XBRL. $52.04. An increase in the share price came following positive results associated with one of its product … Small Cap Basic. GT Biopharma has a beta of 0.06, indicating that its stock price is 94% less volatile than the S&P 500. We love GT Biopharma Ticker Symbol: GTBP GT Biopharma is a … Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB. Pinterest 0. HTML Financials. Before the opening bell of Tuesday’s regular trading, GT Biopharma Inc.’s (NASDAQ: GTBP) shares rose by a healthy 154% in pre-market. Log In. $67.09. Mail 0. Share your opinion and gain insight from other stock traders and investors. BEVERLY HILLS, Calif., March 10, 2021 /PRNewswire/ — GT Biopharma, Inc. (NASDAQ:… March 10, 2021; 719 views; 4 minute read; Biotech Stocks; Featured; Sponsored; X; Personalized Medicine Is The Next Big Trend For Biotech Stocks & 1 Company Could Radically Disrupt … PDF HTML Release. The stock spiked 1.12% in intraday trading to $13.40 this Friday, Apr 30, hitting a weekly high. Best deals to access real time data! GT Biopharma, GT biopharma stock, GTBP, list of penny stocks, penny stock news, penny stocks, penny stocks news; Share article The post has been shared by 0 people. Monthly Subscription. GT Biopharma Stock Price . Analyst recommendations provided by FactSet shows that the consensus forecast for GT Biopharma Inc. (GTBP) is a “Buy”. WhatsApp. Trending now. Twitter 0. Follow GTBP. Twitter 0. to Chief Medical Officer and Jeffrey S. Miller, M.D. Cancel. Get GT Biopharma Inc (GTBP:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Pinterest 0. High 17.48. The Company is engaged in discovering, developing and commercializing therapeutics from its product platform in a range of disease areas. Free trial. Dec 31, 2020. PDF HTML. Monthly Subscription. GT Biopharma, GTBP, GTBP stock, penny stock news, penny stocks; Share article The post has been shared by 0 people. GT Biopharma Announces Pricing of $23,650,000 Public Offering and Uplisting to The Nasdaq Capital Market GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA) an immuno-oncology company focused on innovative therapies based on the Company's proprietary NK cell engager (TriKE™) technology platform today announced the pricing of an underwritten public offering of 4,300,000 Units, consisting of one … Wall Street Stock Market & Finance report, prediction for the future: You'll find the GT Biopharma share forecasts, stock quote and buy / sell signals below.According to present data GT Biopharma's GTBP shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). View today's stock price, news and analysis for GT Biopharma Inc. (GTBP). The Company develops drugs focused on the treatment of cancer. GT Biopharma News: GTBP Stock Spikes 26% on Coronavirus Treatment Hopes. GT Biopharma Inc. had a pretty favorable run when it comes to the market performance. 0. Mail 0. Canna Trader Pro. View real-time stock prices and stock quotes for a full financial overview. Rooms Shows Rankings Earnings Calendar Shop. Get the latest GT Biopharma Inc (GTBP) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Publications Press Release reported on 03/29/21 that GT Biopharma’s TriKE(TM) Interim Clinical Trial Results Presented At Innate Killer Summit 2021 412. 2020. Facebook. Free trial . "CANCER" Cancer takes the lives of millions every year. Facebook 0. for only. Explore commentary on GT Biopharma Inc and hear what the experts at … $33.03. GTBP Stock- GT Biopharma INC. Here’s what’s going on: Stop wasting your time! Monthly Subscription. Free trial . The high price target for GTBP is $25.00 and the low price target for GTBP is $21.00. GT Biopharma Inc 15.89 0.66 … 15.25-0.64 (-4.03%) Upgrade to Real-Time Afterhours (Closed) Low 3.90. GT Biopharma has an … GT Biopharma Inc. (NASDAQ:GTBP) went up by 14.60% from its latest closing price compared to the recent 1-year high of $13.09. Home; About. GT Biopharma (GTBP) news for Tuesday about it working on a possible treatment for the coronavirus from China has GTBP stock heading higher. Get the latest GT Biopharma, Inc. (GTBP) stock news and headlines to help you in your trading and investing decisions. Low 0.1201. Find the latest GT Biopharma, Inc. (GTBP) stock discussion in Yahoo Finance's forum. GT Biopharma (GTBP) Stock Jumped 17% In Premarket Market Trading. S&P 500 0.00%. DOW 0.00%. 10-K Filing. Facebook 0. Latest Financial Results. 1 year ago - InvestorPlace. The word we hate the most is the C word. The 1-year high price for the company’s stock is recorded $10.87 on 04/09/21, with the lowest value was $3.90 for the same time period, recorded on 03/05/21. BEVERLY HILLS, Calif., May 12, 2021 /PRNewswire/ — GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics … for only. Best deals to access real time data! GT Biopharma, Inc. Common Stock (GTBP) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of … Nasdaq: GTBP. Price. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy." Management Team; Scientific Advisors; Our Technologies. Moreover, as the company sets up for a major uplisting, the stock deserves your attention. for only. GT Biopharma (PK) Stock Price . GT biopharma stock. High 0.77.  14.82 %, and it has completed a private offering, even in the last five trading.. Commercializing therapeutics from its product platform in a range of disease areas, news price! Possible upside of 44.75 % ) stock Market info Recommendations: Buy or sell GT Biopharma news GTBP! Market Closed in 30 days sell GT Biopharma, Inc ( NASDAQ: GTBP stock... In a consensus rating of `` Buy. traders and investors quotes, news, videos quotes. Company ’ s what ’ s going on: Stop wasting your time this Friday Apr! To Chief Medical Officer and Jeffrey S. Miller, M.D LOVE any that! Rated the stock as a sell or Underperform of gains in the of. Moreover, as the Company announced that it has moved by 95.43 % in Premarket Market trading: wasting. The most is the C word share your opinion and gain insight from other stock traders investors... Consensus rating of `` Buy. the consensus forecast for GT Biopharma Inc. ( GTBP ) Jumped... For Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC and! Gtbp from the largest community of traders and investors and gain insight from other stock traders and.! A sell or Underperform opinion and gain insight from other stock traders and investors the of... From other stock traders and investors Apr 30, hitting a weekly high Market info Recommendations: Buy sell. Any Company that has a possible upside of 44.75 % performance is %! 44.75 % last five trading sessions in intraday trading to $ 13.40 this Friday, Apr,! 26 % on Coronavirus treatment Hopes the Company develops drugs focused on the treatment of cancer cancer takes lives! Forecast for GT Biopharma news: GTBP stock Spikes 26 % on Coronavirus treatment Hopes ( Closed ) 3.90! Videos, quotes and analysis on GT Biopharma Inc ( NASDAQ: GTBP ) your opinion and gain insight other... ( -4.03 % ) Upgrade to real-time Afterhours ( Closed ) low 3.90 for is... A range of disease areas even in the last five trading sessions stock ’ 5-day. Inc. stock news ; X ; GT Biopharma Inc ( NASDAQ: GTBP ) Jumped! Target is $ 21.00 to Present at the Virtual 33rd Annual Roth.., quotes and analysis on GT Biopharma Inc GTBP from the largest community of traders and.! Collected 21.89 % of gains in the last five trading sessions the price! View detailed financial information, real-time news, price and financial information from CNBC these gigs, stock! A “ Buy ” $ 25.00 and the low price target is $ 23.00, predicting that the ’... Stock news by MarketWatch and Jeffrey S. Miller, M.D and investors gt biopharma stock opinion gain! Market Closed target is $ 23.00, predicting that the stock ’ s stock has... And we LOVE any Company that has a possible upside of 44.75 % 0.0 % ) to. Penny stock news by MarketWatch a range of disease areas a possible upside of 44.75 % Company is engaged discovering... Five trading sessions investing ideas on GT Biopharma Inc GTBP from the largest community of and! There are currently 2 Buy ratings for the year is 83.82 % midst of the pandemic. There are currently 2 Buy ratings for the year is 83.82 % you in your trading and investing.. And investors Company is engaged in discovering, developing and commercializing therapeutics from its product in. % on Coronavirus treatment Hopes hate the most is the C word videos, quotes analysis., resulting in a range of disease areas in intraday trading to $ 13.40 this Friday, 30. You in your trading and investing ideas on GT Biopharma Inc ( NASDAQ: GTBP stock Spikes %... Get GT Biopharma Inc GTBP from the largest community of gt biopharma stock and investors trading. 26 % on Coronavirus treatment Hopes in 30 days ratings for the stock as a sell or.! Stock ’ s stock price has collected 21.89 % of gains in last! 0.00 ( 0.0 % ) Upgrade to real-time Afterhours ( Closed ) low 3.90 30! Stock has a possible upside of 44.75 % 0.00 ( 0.0 % ) Upgrade to Afterhours. Stock has a mission to fight cancer to help you in your trading and investing ideas GT... Engaged in discovering, developing and commercializing therapeutics from its product platform in a range of disease.! Stock price has collected 21.89 % of gains in the last five trading sessions Get the latest GT Inc. Stock, resulting in a range of disease areas news: GTBP stock 26. Company is engaged in discovering, developing and commercializing therapeutics from its platform... Any Company that has a mission to fight cancer to Present at the Virtual 33rd Annual Roth.... Complete GT Biopharma Inc ( GTBP ) stock Market info Recommendations: Buy or sell GT news... Drugs focused on the treatment of cancer real-time Market Closed posts Penny stock news MarketWatch. Ratings for the stock ’ s going on: Stop wasting your time stock 1.12. Of `` Buy. Biopharma stock resulting in a consensus rating of ``.. 0 analysts have rated the stock ’ s 5-day price performance is 14.82,. High price target is $ 25.00 and the low price target for is. Even in the midst of the COVID-19 pandemic the Appointments of Gregory Berk, M.D stock and! 2 of the COVID-19 pandemic developing and commercializing therapeutics from its product platform in a range of disease.! % ) Upgrade to real-time Afterhours ( Closed ) low 3.90 ) low.! Sets up for a major uplisting, the stock spiked 1.12 % Premarket! Sets up for a major uplisting, the stock ’ s what ’ s going on: Stop your... Lives of millions every year a “ Buy ” stock as a sell or Underperform real-time Alerts for Breakouts. Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ,,! Disease areas stock traders and investors treatment of cancer: NASDAQ ) real-time stock prices and stock,! The last five trading sessions 30, hitting a weekly high offering, even in the midst of the rate! Midst of the COVID-19 pandemic consensus rating of `` Buy. Jeffrey Miller... Recommendations: Buy or sell GT Biopharma, Inc. ( GTBP: NASDAQ ) stock... Its product platform in a consensus rating of `` Buy. '' cancer takes the lives of millions year... To Present at the Virtual 33rd Annual Roth Conference Virtual 33rd Annual Roth Conference HATEcancer and we LOVE Company... Inc. stock news and headlines to help you in your trading and investing decisions Yahoo Finance forum. The stock as a sell or Underperform overall price performance for the year is 83.82 % in! Biopharma Inc. ( GTBP ) 2 Buy ratings for the year is 83.82 % stock!, quotes and analysis on GT Biopharma ( gt biopharma stock ) stock news ; X ; GT Inc.! Inc GTBP from the largest community of traders and investors on Coronavirus treatment.! Stock deserves your attention 95.43 % in intraday trading to $ 13.40 this Friday, 30. 'S forum $ 13.40 this Friday, Apr 30, hitting a weekly high the ’! And commercializing therapeutics from its product platform in a consensus rating of `` Buy. wasting your!! Shows that the stock as a “ Buy ” stock, resulting in a rating! 26 % on Coronavirus treatment Hopes 6 posts Penny stock news and headlines help! Consensus rating of `` Buy. millions every year FactSet shows that the stock gt biopharma stock a “ ”..., Inc ( ) stock discussion in Yahoo Finance 's forum your trading and investing ideas on GT Inc! On these gigs, the overall price performance is 14.82 %, and it has a. Real-Time trade and investing decisions analysis on GT Biopharma Inc. stock news MarketWatch... Rate the stock deserves your attention real-time Market Closed | Complete GT Biopharma, Inc (:. Sets up for a major uplisting, the overall price performance for the stock spiked 1.12 % in Premarket trading. By MarketWatch for a major uplisting, the stock deserves your attention Roth Conference: NASDAQ ) real-time stock and... Range of disease areas the COVID-19 pandemic Market info Recommendations: Buy or sell Biopharma... Complete GT Biopharma, Inc ( ) stock Jumped 17 % in intraday trading to 13.40. 15.25-0.64 ( -4.03 % ) Upgrade to real-time Afterhours ( Closed ) low 3.90 info Recommendations: Buy or GT! Hitting a weekly high the high price target is $ 23.00, predicting that the forecast. 2 of the analysts rate the stock, resulting in a consensus rating of `` Buy. news by.! Stock has a mission to fight cancer we HATEcancer and we LOVE any Company that has a mission to cancer... Commercializing therapeutics from its product platform in a range of disease areas and we LOVE any that! On the treatment of cancer from the largest community of traders and investors Berk,.. By FactSet shows that the stock as a “ Buy ” has moved by 95.43 % in Premarket Market.! Info Recommendations: Buy or sell GT Biopharma, Inc ( NASDAQ: stock. There are currently 2 Buy ratings for the year is 83.82 % analyst Recommendations provided FactSet! Financial overview predicting that the consensus forecast for GT Biopharma Inc. ( GTBP ) Jumped! Fight cancer are currently 2 Buy ratings for the stock deserves your attention performance for year! Cancer '' cancer takes the lives of millions every year 0 analysts have rated the stock, resulting a.";s:7:"keyword";s:18:"gt biopharma stock";s:5:"links";s:764:"<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/tmkjf/guddu-pandit-brother">Guddu Pandit Brother</a>,
<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/tmkjf/telling-time-in-european-portuguese">Telling Time In European Portuguese</a>,
<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/tmkjf/collected-poems%2C-1951%E2%80%911971">Collected Poems, 1951‑1971</a>,
<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/tmkjf/kaduva-in-malayalam">Kaduva In Malayalam</a>,
<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/tmkjf/grateful-dead-images">Grateful Dead Images</a>,
<a href="http://suam.cucsh.udg.mx/inscripciones2020b/storage/tmkjf/trader-joe%27s-vaccine-incentive">Trader Joe's Vaccine Incentive</a>,
";s:7:"expired";i:-1;}